Pancreatic Cancer Research

ResearcherHuzhou Central HospitalNo recent work listed

Qiang Yan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6609-5845; OpenAlex author ID A5101575011. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
12
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper

Papers 4

  1. ELK1 Enhances Pancreatic Cancer Progression Via LGMN and Correlates with Poor Prognosis. Co-author DOI 10.3389/fmolb.2021.764900↗
  2. Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer. Last author DOI 10.1136/jitc-2019-000308↗
  3. Mechanism of miR-210 involved in epithelial-mesenchymal transition of pancreatic cancer cells under hypoxia. Last author DOI 10.1080/10799893.2019.1683863↗
  4. Asparaginyl endopeptidase enhances pancreatic ductal adenocarcinoma cell invasion in an exosome-dependent manner and correlates with poor prognosis. Co-author DOI 10.3892/ijo.2018.4318↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xu Dong Sun · 3 shared papers, 2018–2021 · strength 0.30
  2. Mingjie Zhang · 2 shared papers, 2018–2020 · strength 0.18
  3. Jun Ni · 1 shared paper, 2019 · strength 0.12
  4. Chenming Ni · 1 shared paper, 2021 · strength 0.12
  5. Shuwen Han · 1 shared paper, 2021 · strength 0.12
  6. Zhe Yang · 1 shared paper, 2021 · strength 0.12
  7. Weilin Wang · 1 shared paper, 2021 · strength 0.12
  8. Guoping Ding · 1 shared paper, 2020 · strength 0.10
  9. Xiaodong Xu · 1 shared paper, 2020 · strength 0.10
  10. Tao Shen · 1 shared paper, 2020 · strength 0.10
  11. Liping Cao · 1 shared paper, 2020 · strength 0.10
  12. Zhihong Ma · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.